Maier Paul V: insider trades.
Maier Paul V reported 10 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($5.9M), across 2 companies.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 7
- Companies
- 2
- Name as filed
- MAIER PAUL V
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | Director | 9 |
| International Stem Cell CORP | Director | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-11 | International Stem Cell CORP | S | 32,802 | $0.32 | 0 | Form 4 |
| 2026-08-28 | Eton Pharmaceuticals, Inc. | M | 12,500 | $7.31 | 72,245 | Form 4/A |
| 2026-08-28 | Eton Pharmaceuticals, Inc. | S | 13,485 | $60.21 | 59,873 | Form 4/A |
| 2026-08-28 | Eton Pharmaceuticals, Inc. | S | 128 | $61.77 | 59,745 | Form 4/A |
| 2026-08-28 | Eton Pharmaceuticals, Inc. | M | 50,000 | $3.78 | 109,745 | Form 4/A |
| 2026-08-28 | Eton Pharmaceuticals, Inc. | S | 36,387 | $58.64 | 73,358 | Form 4/A |
| 2026-08-28 | Eton Pharmaceuticals, Inc. | M | 50,000 | $3.78 | 109,745 | Form 4 |
| 2026-08-28 | Eton Pharmaceuticals, Inc. | S | 128 | $61.77 | 59,745 | Form 4 |
| 2026-08-28 | Eton Pharmaceuticals, Inc. | S | 13,485 | $60.21 | 59,873 | Form 4 |
| 2026-08-28 | Eton Pharmaceuticals, Inc. | S | 36,387 | $58.64 | 73,358 | Form 4 |
Questions
What stock did Maier Paul V buy or sell?
Maier Paul V reported 10 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($5.9M), across 2 companies.
Is Maier Paul V the same person as other filers with this name?
This page covers SEC CIK 1182615 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/maier-paul-v-1182615.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.